Related Experiment Videos
Recombinant tissue plasminogen activator (rt-PA) in fibrinolytic therapy
1Department of Biopharmaceutical Manufacture, Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany.
Journal of Biotechnology
|July 9, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
International journal of pharmaceutics·2008
Transgenic manufactured biopharmaceuticals: a new method of drug manufacturing.
Expert opinion on investigational drugs·2005
Improving natural principles with genetic engineering: TNK-tissue plasminogen activator.
Arzneimittel-Forschung·2001
Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli.
Applied and environmental microbiology·2001
Do plants used for vaccine production contribute to immunogenicity and immunoprotection beyond antigen expression?
Journal of biotechnology·2026
Cysteine-condensed thiazolidine as an effective cysteine source for CHO cell culture.
Journal of biotechnology·2026
Newly isolated Corynebacterium glutamicum strain PP80 for use in high-temperature L-glutamic acid fermentation.
Journal of biotechnology·2026
Irisin and endocrine-metabolic indicators as predictors of IVF-ET pregnancy outcomes in Chinese women with PCOS.
Frontiers in endocrinology·2026
A transient RNP compartment boosts translation and growth of mammalian oocytes.
Science advances·2026